SESEN BIO INC's ticker is SESN and the CUSIP is 817763105. A total of 58 filers reported holding SESEN BIO INC in Q4 2020. The put-call ratio across all filers is 12.41 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $3,410,000 | +47.6% | 1,311,672 | -23.4% | 0.35% | +39.2% |
| Q4 2020 | $2,311,000 | -5.6% | 1,711,672 | -2.1% | 0.25% | -9.1% |
| Q3 2020 | $2,449,000 | +94.5% | 1,749,219 | 0.0% | 0.28% | +139.1% |
| Q2 2020 | $1,259,000 | +28.3% | 1,749,219 | 0.0% | 0.12% | -36.1% |
| Q1 2020 | $981,000 | -48.9% | 1,749,219 | -5.2% | 0.18% | -37.7% |
| Q4 2019 | $1,919,000 | -73.4% | 1,845,616 | -70.0% | 0.29% | -66.0% |
| Q3 2019 | $7,202,000 | -22.1% | 6,155,323 | -0.2% | 0.85% | -6.4% |
| Q2 2019 | $9,249,000 | +71.4% | 6,166,175 | +17.7% | 0.91% | +25.9% |
| Q1 2019 | $5,397,000 | -27.5% | 5,239,557 | 0.0% | 0.72% | -35.7% |
| Q4 2018 | $7,440,000 | -22.2% | 5,239,557 | +17.9% | 1.12% | +68.2% |
| Q3 2018 | $9,558,000 | +10.3% | 4,445,557 | 0.0% | 0.67% | +10.2% |
| Q2 2018 | $8,669,000 | – | 4,445,557 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,711,672 | $2,311,000 | 0.25% |
| Eversept Partners, LP | 1,559,824 | $2,105,762 | 0.25% |
| Virtu Financial LLC | 270,004 | $365,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 147,452 | $199,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 838,500 | $1,132,000 | 0.02% |
| MIRABELLA FINANCIAL SERVICES LLP | 88,350 | $119,000 | 0.02% |
| Stratos Wealth Partners, LTD. | 263,300 | $355,000 | 0.01% |
| AJ WEALTH STRATEGIES, LLC | 79,365 | $107,000 | 0.01% |
| Schonfeld Strategic Advisors LLC | 349,176 | $471,000 | 0.01% |
| Qube Research & Technologies Ltd | 330,303 | $446,000 | 0.01% |